Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients [Phase 2]
Phase 2 trial evaluating bicalutamide with or without metformin for biochemical recurrence in overweight/obese prostate cancer patients; stu…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating cabozantinib with androgen ablation in androgen-dependent metastatic prostate cancer completed with posted…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of stereotactic body radiation therapy for prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer [NA]
A terminated clinical trial comparing transperineal and transrectal MRI-targeted biopsy for prostate cancer detection and characterization, …
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer [Phase 1, Phase 2]
Clinical trial update for 64Cu-SAR-bisPSMA PET imaging in prostate cancer across Phase 1 and Phase 2.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating enhanced systemic therapy combined with local treatment for primary and metastatic lesions in oligometastatic prost…
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer [Phase 2]
Phase 2 trial of multi-epitope TARP peptide autologous dendritic cell vaccination in men with stage D0 prostate cancer (terminated; results …
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma [Phase 2]
Phase II open-label study evaluating biweekly docetaxel with androgen-deprivation therapy in previously untreated metastatic prostate cancer…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation [Phase 2]
Phase 2 study evaluating olaparib in newly diagnosed metastatic castration-resistant prostate cancer patients with HRR gene mutations.
-
CLINICAL_TRIALS trial_result · 2022-02-24Clinical Trial Update: Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours [Phase 1, Phase 2]
Phase I/II clinical trial evaluating the safety and tolerability of LiPlaCis in patients with advanced or refractory tumours; trial complete…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Ultralow Versus Standard Pneumoperitoneum Pressure [NA]
Clinical trial update for ultralow versus standard pneumoperitoneum pressure in prostate cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy [Phase 2]
Phase 2 trial evaluating sorafenib in combination with docetaxel for prostate cancer that progressed after hormone therapy has completed wit…
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases [NA]
Clinical trial update for Radium 223 in castration-resistant prostate cancer with bone metastases; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent [Phase 4]
A Phase 4 trial compared cabazitaxel to switching to another AR-targeted agent (enzalutamide or abiraterone) in metastatic castration-resist…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic [Phase 2]
Phase 2 trial evaluating treatment of metastatic castration-resistant prostate cancer using circulating tumor cell kinetics.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy [Phase 2]
Phase 2 trial update on soy derivatives for managing hot flashes in men undergoing androgen deprivation therapy for prostate cancer; study t…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 [Phase 2]
Phase 2 trial assessing biomarker-driven therapy with nivolumab and ipilimumab for metastatic hormone-resistant prostate cancer expressing A…
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes [Phase 2]
Phase 2 BrUOG 337 trial evaluating olaparib before radical prostatectomy in advanced prostate cancer was terminated; results have been poste…
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: MR Image Guided Therapy in Prostate Cancer [Phase 2]
Phase 2 clinical trial update on MR image-guided therapy for prostate cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Prostate Cancer Screening Trial Using Imaging
Clinical trial completion for a prostate cancer screening study using imaging; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer [Phase 2]
Phase 2 trial evaluating adjuvant statin therapy in patients after radical prostatectomy for locally advanced prostate cancer completed.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer [NA]
Clinical trial update on stereotactic body radiotherapy (SBRT) for prostate cancer; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC [Phase 3]
Phase 3 study evaluating apalutamide plus androgen deprivation therapy (ADT) versus ADT alone in men with metastatic hormone-sensitive prost…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC [Phase 3]
Phase 3 trial evaluating apalutamide added to androgen deprivation therapy versus ADT alone in metastatic hormone-sensitive prostate cancer;…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer [Phase 3]
Phase 3 trial update evaluating decision aids to improve knowledge for patients newly diagnosed with prostate cancer; results have been post…